Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Ups Forecast On Beauty, Health Results, Despite 'A Lot Of Variability'

Executive Summary

P&G beauty division's sales grow on premium skin care lines and despite price increases as health care sales grow 5% on volume, particularly in oral care. Net earnings in latest quarter grow 9% to $2.78bn as results prompt investor activity with share price slipping 2.7% in trading at nearly twice average volume.

You may also be interested in...



P&G Positions Joy Women's Razor To Bring Shaving 'Back To The Essentials'

P&G launches joy brand for women as a no-frills razor for a reasonable price, contrasting in positioning with Venus. Brand and glee shaving preparations are sold exclusively in Walmart stores to target millennial and generation Z age groups.

P&G Raises Forecast On Strong First Half, Notes Price Increases As Potential Drag

P&G reports 4% organic growth in its fiscal 2019 Q2, building on a strong Q1 and prompting it to raise full-year organic guidance 1%. CFO Jon Moeller warns, however, possible market volatility and competitor activity related to potential price increases could sink its positive estimate.

P&G Grooming Quits Counting Blades, Innovates In New Directions While Battling DTC Disruptors

In the six years since Dollar Shave Club’s viral video and pioneering business model upended the men’s razor market, P&G’s grooming business has been scrambling to reestablish itself and win back market share. The division’s first-quarter results suggest that its fresh innovation approach, updated messaging and direct-to-consumer investments are paying off, though significant competitive challenges remain.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148750

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel